These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27107622)

  • 1. Epidemiology of Clostridium difficile infections in Australia: enhanced surveillance to evaluate time trends and severity of illness in Victoria, 2010-2014.
    Worth LJ; Spelman T; Bull AL; Brett JA; Richards MJ
    J Hosp Infect; 2016 Jul; 93(3):280-5. PubMed ID: 27107622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
    Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID).
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Wilcox MH
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1949-1956. PubMed ID: 27590621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a Victorian statewide surveillance programme to evaluate the burden of healthcare-associated Staphylococcus aureus bacteraemia and Clostridioides difficile infection in patients with cancer.
    Valentine JC; Hall L; Verspoor KM; Gillespie E; Worth LJ
    Intern Med J; 2022 Jul; 52(7):1215-1224. PubMed ID: 33755285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
    Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA
    PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel community Clostridium difficile infection (CDI) surveillance in Scotland, April 2013 to March 2014.
    Banks A; Brown DJ; Mather H; Coia JE; Wiuff C
    Anaerobe; 2016 Feb; 37():49-53. PubMed ID: 26708405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.
    Furuya-Kanamori L; Riley TV; Paterson DL; Foster NF; Huber CA; Hong S; Harris-Brown T; Robson J; Clements AC
    J Clin Microbiol; 2017 Jan; 55(1):216-225. PubMed ID: 27807147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.
    Gravel D; Miller M; Simor A; Taylor G; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S; Boyd D; Mulvey M;
    Clin Infect Dis; 2009 Mar; 48(5):568-76. PubMed ID: 19191641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study.
    Hensgens MP; Dekkers OM; Demeulemeester A; Buiting AG; Bloembergen P; van Benthem BH; Le Cessie S; Kuijper EJ
    Clin Microbiol Infect; 2014 Dec; 20(12):O1067-74. PubMed ID: 25040463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
    Daniel A; Rapose A
    J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study.
    Drabek J; Nyc O; Krutova M; Stovicek J; Matejkova J; Keil R
    Ann Clin Microbiol Antimicrob; 2015 Dec; 14():55. PubMed ID: 26698842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characterization and risk factors of Clostridium difficile infection in elderly patients in a Chinese hospital.
    Lihua Z; Danfeng D; Cen J; Xuefeng W; Yibing P
    J Infect Dev Ctries; 2015 Apr; 9(4):381-7. PubMed ID: 25881527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of Clostridium difficile infection in long-term care facilities in Monroe County, New York.
    Pawar D; Tsay R; Nelson DS; Elumalai MK; Lessa FC; Clifford McDonald L; Dumyati G
    Infect Control Hosp Epidemiol; 2012 Nov; 33(11):1107-12. PubMed ID: 23041808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection in children: epidemiology and risk of recurrence in a low-prevalence country.
    Lo Vecchio A; Lancella L; Tagliabue C; De Giacomo C; Garazzino S; Mainetti M; Cursi L; Borali E; De Vita MV; Boccuzzi E; Castellazzi L; Esposito S; Guarino A
    Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):177-185. PubMed ID: 27696233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to: Surveillance of Clostridium difficile infections.
    Krutova M; Kinross P; Barbut F; Hajdu A; Wilcox MH; Kuijper EJ;
    Clin Microbiol Infect; 2018 May; 24(5):469-475. PubMed ID: 29274463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Detecting and Isolating Clostridium difficile Carriers at Hospital Admission on the Incidence of C difficile Infections: A Quasi-Experimental Controlled Study.
    Longtin Y; Paquet-Bolduc B; Gilca R; Garenc C; Fortin E; Longtin J; Trottier S; Gervais P; Roussy JF; Lévesque S; Ben-David D; Cloutier I; Loo VG
    JAMA Intern Med; 2016 Jun; 176(6):796-804. PubMed ID: 27111806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
    Pakyz AL; Jawahar R; Wang Q; Harpe SE
    J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.
    Jarvis WR; Schlosser J; Jarvis AA; Chinn RY
    Am J Infect Control; 2009 May; 37(4):263-70. PubMed ID: 19278754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.